Implementation of Dyadic Care to Support Clinical, Administrative, and Service Wraparound Needs for the Opioid-Exposed Mother and Infant [0.03%]
实施二元护理以支持阿片类药物暴露的母婴的临床、管理和服务需求
Shahla M Jilani,Hendrée E Jones,Jonathan M Davis et al.
Shahla M Jilani et al.
Objectives: Although a dyadic approach to clinical care is recommended for opioid-exposed mothers and their infants, there is a lack of practice-based guidance on clinical implementation. To address this knowledge gap, a ...
Prevalence of Alcohol Use Disorder and Alcohol-related Liver Disease in Women Undergoing Cervical Cancer Screening: A Missed Opportunity to Screen? [0.03%]
接受宫颈癌筛查的女性中酒精使用障碍和酒精相关性肝病的患病率：一次被忽视的筛查机会吗？
Mary Thomson,Katelyn M Tessier,Cresta Jones et al.
Mary Thomson et al.
Objectives: Early recognition of alcohol use disorder (AUD) in women can reduce the risk of developing alcohol-related liver disease (ALD). For many women, reproductive health visits, including cervical cancer screening m...
ASAM Consensus Standards for Substance Use Disorder Care Capabilities in Hospitals and Emergency Departments [0.03%]
物质使用障碍诊疗能力的阿桑共识标准：医院和急诊科版
Sarah Wakeman,Chethan Bachireddy,Arianna Campbell et al.
Sarah Wakeman et al.
Importance: The morbidity, mortality, and costs associated with untreated substance use disorder (SUD) in hospitals are substantial. In 2017 alone, $13 billion was spent on medical costs associated with SUD care in hospit...
Use of Medication for Addiction Treatment Among Physicians and Pharmacists Monitored for Substance Use Disorder by One State Physician Health Program [0.03%]
一个州的医师健康项目监控下药物使用障碍的医师和药剂师使用麻醉药品治疗药物滥用情况的研究
Cristiana N P Araujo,Alexandria Polles,Lisa J Merlo
Cristiana N P Araujo
Objectives: This study explored the utilization of medication for addiction treatment (MAT) by participants in one state physician health program (PHP) over the course of 30 years, and reviewed patterns of use and monitor...
An Equitable Behavioral Engagement Framework for Stimulant Medication Treatment in Methamphetamine Use Disorder [0.03%]
阿片类药物治疗中的公平行为参与框架甲氨蝶呤使用紊乱
Deirdra Kelly,Ann Lites,Arianna Campbell et al.
Deirdra Kelly et al.
The 2024 American Society of Addiction Medicine and American Academy of Addiction Psychiatry Clinical Practice Guideline includes a conditional recommendation for long-acting methylphenidate as a pharmacologic option for amphetamine-type st...
Perspectives of Youth Experiencing Homelessness on Substance Use and Harm Reduction: A Qualitative Youth Participatory Action Research Study [0.03%]
无家可归青年对药物使用和危害减少的看法：一种定性青年参与行动研究
André Robinson,Samantha LeBouef,Wren Krahl et al.
André Robinson et al.
Objectives: Youth experiencing homelessness (YEH) report higher substance use than stably housed youth, yet their perspectives and system supports are poorly understood. This youth participatory action research examines Y...
Case Report: Oral-Nasal Damage in a Person Using Fentanyl and Xylazine [0.03%]
个例报告：使用芬太尼和赛拉嗪者的口腔-鼻部损伤
Julie Kmiec,Garret Choby
Julie Kmiec
Background: Xylazine, an alpha-2-adrenergic agonist, was added to illicitly manufactured fentanyl within the past decade. Intranasal drug use is common and associated with damage to nasal structures and the palate. There ...
Postmortem Toxicology Positivity for Medications for Opioid Use Disorder in Illinois Unintentional Opioid Overdose Deaths 2019-2024 [0.03%]
2019年至2024年伊利诺伊州意外阿片类药物过量死亡中用于治疗阿片类药物使用障碍的药物的法医毒理学阳性结果分析
Corey Hazekamp,Maryann Mason
Corey Hazekamp
Objectives: Currently, most unintentional opioid overdose deaths (OODs) in the United States are attributed to fentanyl. Buprenorphine and methadone reduce mortality associated with opioid use disorder. Despite the protec...
Opioid Agonist Treatment Use Among First Nation Peoples in Ontario, Canada: A Repeated Cross-sectional Study of Prevalence Trends From 2013 to 2023 [0.03%]
加拿大安大略省第一民族人群的阿片类激动剂治疗使用情况：2013年至2023年的重复横断面研究趋势分析
Nevena Rebić,Shaleesa Ledlie,Bisola Hamzat et al.
Nevena Rebić et al.
Objectives: The opioid toxicity crisis has disproportionately harmed First Nation Peoples, prompting efforts to expand access to opioid agonist therapy (OAT). We described trends in OAT use among this population in Ontari...
Advancing Kratom Science and Regulation: A Comparative Framework With Cannabis [0.03%]
kratom科学研究与监管：与大麻的比较框架
Ynhi T Thomas,Mubeen Iqbal,Chung J Mun et al.
Ynhi T Thomas et al.
Kratom (Mitragyna speciosa) is a psychoactive botanical with a long history of use in Southeast Asia and growing uptake in the United States for its analgesic, stimulant, and mood-altering properties. The evidence base remains limited, and ...